title: The high-performance liquid chromatographic fingerprints study of Awei capsules.
abstract: BACKGROUND
  Awei Capusules are Hospital preparation for Hyperlipidemia. It was composed by Awei, Magnoliae Officinalis and Polygonum Bistoral etc. Manufacture and quality standard of Awei Capusules had been studied. Results of animal pharmacodynamic and clinical study all displayed that Awei Capusules can reduce serum levels of TC, TG, LDL-C, increases HDL-C/TC. It was safe. It could improve hemorrheology and vessel function of blood stasis animal. On the basis of these, we studied on fingerprint of Awei capsule.
  
  
  METHODS
  The gradient elution method was used for analyzing samples on HPLC. Fingerprint similarity calculation software was used for data analysis.
  
  
  RESULTS
  We got a good separation of Awei Capusules peaks. There were 15 peaks in fingerprint of Awei capusles. Gallic acid, magnolol and honokiol were identified.
  
  
  CONCLUSIONS
  HPLC fingerprinting of Awei Capusules can provide to reference. It can control preparations quality of Awei Capusules.
authors: The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
authors: Rong
authors: R
authors: Han
authors: Jie
authors: J
authors: Xue
authors: Erwei
authors: E
authors: Hua
authors: Longlong
authors: L
authors: Zhou
keywords: Awei capusules; fingerprints; high-performance liquid chromatographic
references: J Biol Chem. 2003 Sep 12;278(37):35501-7
references: 12816951
references: J Pharm Pharmacol. 1994 Apr;46(4):286-90
references: 8051612
references: Arch Pharm Res. 2000 Feb;23(1):46-9
references: 10728656
references: Thromb Res. 1988 Jun 15;50(6):757-65
references: 3413728
references: Life Sci. 1997;61(19):1961-71
references: 9364201
references: Pharmacogn Mag. 2011 Jul;7(27):177-85
references: 21969787
references: Eur J Pharmacol. 2001 Jun 22;422(1-3):159-67
references: 11430926
references: Pharmacogn Mag. 2011 Apr;7(26):116-20
references: 21716620
references: Pharmacogn Mag. 2010 Apr;6(22):111-5
references: 20668576
references: Pharmacogn Mag. 2010 Apr;6(22):83-8
references: 20668571